EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis

Paul Freedman, Bettina Schock iD, Steven O'Reilly

Cells · 2024

DOI: 10.3390/cells13141205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Paul Freedman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, Durham University, South Road, Durham DH1 3LE, UK. Hauptthemen laut MEDLINE: Interleukins, Skin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis (SSc) is an autoimmune connective tissue disease with a triad of features that include vascular abnormalities, inflammation and skin and lung fibrosis. At the core of the disease is the activation of myofibroblasts from quiescent fibroblasts and this can be modified by various cytokines. IL-41 is a recently described cytokine that was initially characterised as an adipokine as it was highly expressed in adipocytes and adipose tissue. However, it has recently been identified as being widely expressed and has immunomodulatory functions. This study examined the circulating levels of IL-41 and its expression in skin biopsies. We demonstrated significantly reduced levels of IL-41 in diffuse SSc that was also mirrored in the skin of SSc patients. AMPK has been proposed as a downstream target of IL-41, so we also measure mammalian target of rapamycin in skin and found that this is elevated in SSc patients. We speculate that IL-41 maybe an antifibrotic cytokine and its reduction may facilitate the activation of fibroblasts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InterleukinsSkinAdultAgedFemaleHumansMaleMiddle AgedCytokinesFibroblastsScleroderma, DiffuseScleroderma, SystemicTOR Serine-Threonine KinasesAdipokines

Stichwörter der Autor:innen

IL-41cytokinefibrosisfibroticsystemic sclerosis

Substanzen

CytokinesInterleukinsTOR Serine-Threonine KinasesMYDGF protein, humanMetrnl protein, humanAdipokines

Autor:innen und Institutionen

  • Department of Biosciences, Durham University, South Road, Durham DH1 3LE, UK.
  • The Wellcome-Wolfson Institute for Experimental Medicine, Queens University Belfast, Belfast BT9 7BL, UK.

ORCID-Profile: Bettina Schock

Zitieren

APA

Freedman, P., Schock, B., & O'Reilly, S. (2024). The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis. Cells. https://doi.org/10.3390/cells13141205

Vancouver

Freedman P, Schock B, O'Reilly S. The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis. Cells. 2024. doi:10.3390/cells13141205

BibTeX
@article{Freedman2024,
  author = {Freedman, Paul and Schock, Bettina and O'Reilly, Steven},
  title = {The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13141205}
}
Kostenlos starten →